These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 15065611

  • 1. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A, Bartlett RP, Moder KG, Chang-Miller A, Cardel LK, Heit JA, Homburger HA, Petterson TM, Christianson TJ, Nichols WL.
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G.
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [Abstract] [Full Text] [Related]

  • 3. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 4. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 5. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec 15; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 15; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 15; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR, Pyke S, Iannaccone L, Brancaccio V.
    Thromb Haemost; 1995 May 15; 73(5):768-73. PubMed ID: 7482401
    [Abstract] [Full Text] [Related]

  • 9. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI.
    Korean J Lab Med; 2009 Dec 15; 29(6):497-504. PubMed ID: 20046079
    [Abstract] [Full Text] [Related]

  • 10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Dec 15; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 11. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
    Simmons DP, Herskovits AZ, Battinelli EM, Schur PH, Lemire SJ, Dorfman DM.
    Clin Chem Lab Med; 2018 Jul 26; 56(8):1289-1296. PubMed ID: 27305702
    [Abstract] [Full Text] [Related]

  • 12. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C.
    Thromb Haemost; 2009 Mar 26; 101(3):577-81. PubMed ID: 19277423
    [Abstract] [Full Text] [Related]

  • 13. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 26; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Obermoser G, Bitterlich W, Kunz F, Sepp NT.
    Int Arch Allergy Immunol; 2004 Oct 26; 135(2):148-53. PubMed ID: 15345914
    [Abstract] [Full Text] [Related]

  • 15. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb 26; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 16. [Lupus anticoagulants in patients with systemic lupus erythematosus].
    Matsuura Y, Nawata Y, Miike S, Hiraguri M, Kita Y, Kurasawa K, Takabayashi K, Oh H, Iwamoto I, Saito Y.
    Ryumachi; 1996 Feb 26; 36(1):16-24. PubMed ID: 8711533
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J, Musiał J, Jankowski M, Grzywacz M, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov 26; 1(5):310-2. PubMed ID: 9273202
    [Abstract] [Full Text] [Related]

  • 18. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J, Meijer P, Vermylen J.
    Thromb Haemost; 1999 Jun 26; 81(6):929-34. PubMed ID: 10404770
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E, Magder LS, Petri M.
    J Rheumatol; 2002 Dec 26; 29(12):2531-6. PubMed ID: 12465147
    [Abstract] [Full Text] [Related]

  • 20. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y, Gu JY, Kim HK.
    J Thromb Thrombolysis; 2022 Aug 26; 54(2):318-322. PubMed ID: 35841477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.